Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases

Not Applicable

Completed

• Conditions: Dysphagia; Neuromuscular Diseases
• Interventions: Other: Sydney Swallow Questionnaire

• Registration Number: NCT02845362
• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Brief Summary

Measurements of dysphagia severity are important when making management decisions and in the objective evaluation of swallowing impairments. The Sydney Swallow Questionnaire (SSQ) is a validated self-report inventory using a visual analogue scale. This questionnaire permits a quantitative, sensitive, specific, repeatable and easily responsive evaluation of dysphagia in different pathology. Opposed to largely used videofluoroscopy swallowing study and endoscopy examinations, the SSQ is noninvasive, less expensive, avoids radiation exposure and enables a readily available assessment. Validated French version is not yet available. In the first phase of the study the investigators will validated this translation in dysphagic patients and control. Secondly, the investigators will validate the SSQ in Neuromuscular patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-07-15
• Study First Submitted QC: 2016-07-26
• Study First Posted: 2016-07-27
• Study Start: 2016-08
• Primary Completion: 2018-07
• Study Completion: 2018-10
• Status Verified: 2019-04
• Last Update Submitted: 2019-04-11
• Last Update Posted: 2019-04-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Phase 1:

Group 1:

• Healthy participants
• Able to speak, read and write in French
• Aged at least 18 years old

Group 2:

• Patients, with symptoms indicative of a deglutition disorder, referred for a videofluoroscopic study to the Otolaryngology, Head and Neck Surgery Department, Voice and Swallowing Clinic
• Able to speak, read and write in French
• Aged at least 18 years old

Phase 2:

• Clinical diagnosis of neuromuscular diseases
• Able to understand French

Exclusion Criteria

Phase 1:

Group 1:

• History of neurological or neuromuscular disease
• History of any diagnosticated swallowing disorder

Group 2:

• Patients who could not be cataloged as dysphagic or non-dysphagic after the videofluoroscopic study evaluation
• Patients unable to answer the questionnaire

Phase 2:

• Patients who could not be cataloged as dysphagic or non-dysphagic
• Patients unable to answer the questionnaire

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Dysphagia assessment	Sydney Swallow Questionnaire	-

Primary Outcome Measures

Name	Time	Method
Sydney Swallow Questionnaire	10 minutes	The participants were asked to fill out these questionnaires during the outpatient visit.

Trial Locations

Locations (2)

Cliniques universitaires Saint-Luc; 🇧🇪 Brussels, Belgium

Cliniques universitaires Saint Luc; 🇧🇪 Brussels, Belgium